官方微信官方微博网站地图联系我们English中国科学院
其他功能
联系我们
地理位置
所长信箱
网站地图
留言板
通知公告
为您服务
为您链接
域名跳转
学术报告
现在位置:首页>其他功能>学术报告
9月12日:Exploit clinical benefit of biomaterials for orthopedic therapies: challenge and opportunities
2017-09-05 | 【】【打印】【关闭】                

  报告人:Prof. Chaozong Liu

  John Scale Centre for Biomedical Engineering

  Division of Surgery and Interventional Science

  University College London

  The Royal National Orthopaedic Hospital, Stanmore

  报告时间:9月12日(周二)上午10点

    报告地点:理化楼三楼学术厅

  Abstract:

  UCL is one of the global top research intensive universities on a research output dominated by its Biomedical and Engineering Faculties. UCL’s contribution to the programme will be led by Institute of Orthopaedics and Musculoskeletal Science (IOMS) which is an internationally leading Centre of research and postgraduate training. Its research straddling medical and bio-medical engineering applications. It has reputation and track record for innovative translation research, and has established expertise in technology transferring such as Stanmore Implant Worldwide. IOMS and staffs from the Royal National Orthopaedic Hospital lead units of major importance in clinical care and are at the cutting edge of research and development in implant innovation, cell-engineering and rapid fabrication of tissues. These have applications in musculoskeletal system and vascular regeneration. IOMS provides a unique environment for collaboration between scientists, engineers, and clinicians in an Academic Health Sciences Centre model, in order to speed up the development of improvements in patient care.

  报告人简介:

  Bio_Chaozong Liu

  E-mail: Chaozong.Liu@ucl.ac.uk; Tel: 020 8954 9427

  Dr Chaozong Liu is an associate professor in Biomedical Engineering, the programme leader of MSc in Musculoskeletal Science, and the group leader of UCL Biomaterials & Osteochondral Tissue Engineering within the Division of Surgery & Interventional Science University College London. He has several years’ experience of biomaterials processing and development of medical devices.

  Dr Liu’s current research is directed toward the development of enhanced medical devices for treating musculoskeletal disorders, tissue repair and regeneration. This is a growing area of interest at UCL Surgical & Interventional Science. His research in this area is supported by ARUK, Innovate UK, Horizon2020, EPSRC MeDe Innovation Centre and RoseTree Trusts, and from Fitzpatrick Referrals Ltd. He has developed a new osteochondral scaffold technology that is likely to have a strong potential in regeneration of bone and cartilage for early intervention of osteoarthritis. Preclinical study has demonstrated that the new osteochondral scaffold has the strength needed to bear the physical load of the joints and its patented biomedical structure encourages consistent cartilage fill. A glimpse of how this scaffold will perform has been given, with promising results, by Professor Noel Fitzpatrick of the Channel 4 TV series Supervet, where it was implanted in a pet dog shoulder to treat a large osteochondral defect. The recent awards from Innovate UK-MoST and EU HORIZON2020 have significantly boosted his research in this field.

来源:固体润滑国家重点实验室
评 论
Copyright (©) 中国科学院兰州化学物理研究所*办公室 承制 版权所有
未经中国科学院兰州化学物理研究所书面特别授权,请勿转载或建立镜像,违者依法必究
地址 Add:中国·兰州天水中路18号 邮编 P.C.:730000
E-Mail:webeditor@licp.cas.cn  陇ICP备05000312号    Best view 1024*768 IE6.0